As part of our research group on Tumor Resistance to Treatment (TumHyp), we are investigating the molecular mechanisms underlying cancer cells' resistance to chemotherapy, radiation therapy, and immunotherapy.

Project Leader (PI) | Carine Michiels

Carine Michiels is a full professor at the University of Namur and a member of the Narilis Institute.

View Carine Michiels' profile in the UNamur directory. 

Carine Michiels

Research within the TumHyp Group

The TumHyp research group studies the mechanisms of tumor progression and resistance to chemotherapy, radiation therapy, and immunotherapy, with the goal of developing new strategies to overcome treatment resistance or recurrence. In this context, the group is investigating the role of various physical and cellular mechanisms of resistance and invasiveness, such as tumor hypoxia, cell death, senescence, inflammation, and the interaction of cancer cells with the tumor microenvironment. 

Numerous studies have addressed the question of how to overcome the intrinsic or acquired resistance of cancer cells to radiation therapy. In this context, current research aims to identify the genes involved in the intrinsic resistance of glioblastoma to radiation therapy. In addition, the induction of cell death, senescence, and cell cycle arrest following radiation therapy is being studied in head and neck, pancreatic, and lung cancers. The use of charged-particle radiation therapy, either alone or in combination with gold nanoparticles or immunotherapy, to enhance the destruction of cancer cells, synthetic lethality, or to promote an inflammatory tumor microenvironment and an antitumor immune response, is of particular interest.

Current Research Programs

  • Study of Glioblastoma Resistance to Temozolomide Combined with Radiation Therapy (X-rays vs. Protons): The Role of Extracellular Vesicles
  • Unraveling the dynamic interaction between radiation-induced microenvironment senescence and tumor development in the context of soft tissue sarcoma
  • Immunogenicity of cancer cells induced by radiation therapy
  • Development of a personalized neutron-capture therapy using theranostic vectors
  • Identification of genes involved in intrinsic resistance to temozolomide combined with proton therapy for the treatment of glioblastomas
  • Study of the pro-senescence response to anticancer treatments in HPV-positive versus HPV-negative head and neck cancers
  • Study of the radiosensitizing effect of gold nanoparticles
  • Modulation of tumor-induced immunosuppression by proton therapy to enhance the effects of the PD-1 immune checkpoint inhibitor
  • In vitro and in vivo study of the effects of FLASH proton therapy: from ferroptosis, oxidative stress, and senescence to endoplasmic reticulum and mitochondrial stress”

Our Publications

Contact